: A staple for value investors, focusing on its next-generation immunology drugs to offset the patent loss of its blockbuster drug Humira.
: The top pick for those looking at Indian markets, cited as a long-term leader in specialty drugs. top pharma stocks to buy now
: Recognized for its strong clinical momentum in oncology and its leading HIV franchise, with consistent revenue growth reported recently. Global & High-Growth Tickers : A staple for value investors, focusing on
AI responses may include mistakes. For financial advice, consult a professional. Learn more The Best Healthcare Stocks to Buy | Morningstar Global & High-Growth Tickers AI responses may include
: Ranked as a "Best Buy" by Morningstar due to its "Wide Economic Moat" and dominance in the GLP-1 (weight loss/diabetes) sector.
: Often recommended as a high-yield dividend play, currently viewed as undervalued by some analysts following the post-pandemic normalization of COVID-19 product sales.